GR 205171
|
|
GR 205171 Eigenschaften
- Siedepunkt:
- 542.5±60.0 °C(Predicted)
- Dichte
- 1.39±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- L?slichkeit
- Soluble in DMSO
- pka
- 9.13±0.10(Predicted)
- Aggregatzustand
- Solid
- Farbe
- Light yellow to yellow
- CAS Datenbank
- 168266-90-8
Sicherheit
GR 205171 Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Yellowish solidGR 205171 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
GR 205171 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 19)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Hubei Jusheng Technology Co.,Ltd. | 18871490254 |
linda@hubeijusheng.com | CHINA | 28172 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32161 | 58 |
TargetMol Chemicals Inc. | |
support@targetmol.com | United States | 38631 | 58 |
Beijing HuaMeiHuLiBiological Chemical | 010-56205725 |
waley188@sohu.com | China | 12335 | 58 |
Fan De(Beijing) Biotechnology Co., Ltd. | 15911056312 |
liming@bio-fount.com | China | 9729 | 58 |
Jinan Ruisi Pharmaceutical Technology Co., LTD | 0531-69900633 18340090523 |
changyuan20@163.com | China | 2670 | 58 |
ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 |
sales@chemegen.com | China | 11218 | 58 |
Absin Bioscience Inc. | 021-38015121 15000105423 |
wulan@absin.cn | China | 24731 | 58 |
Shanghai hongqu biomedical technology co. LTD | 88888888888 |
hongquchem@qq.com | China | 5132 | 58 |
cjbscvictory | 13348960310 13348960310 |
3003867561@qq.com | China | 10524 | 58 |
- GR 205171
- Vofopitant (GR 205171)
- 3-Piperidinamine, N-[[2-methoxy-5-[5-(trifluormethyl)-1H-tetrazol-1-yl]phenyl]methyl]-2-phenyl, (2S,3S)
- 3-Piperidinamine, N-[[2-methoxy-5-[5-(trifluormethyl)-1H-tetrazol-1-yl]phenyl]methyl]-2-phenyl, (2S-cis-)
- Vofopitant
- GR205171; GR-205171
- N-[[2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenylpiperidin-3-amine
- 3-Piperidinamine, N-[[2-methoxy-5-[5-(trifluoromethyl)-1H-tetrazol-1-yl]phenyl]methyl]-2-phenyl-, (2S,3S)-
- 168266-90-8
- C21H23F3N6O